Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Facial Irritation Study of Retin-A Micro vs Epiduo
NCT00952523Phase 4Completed
- Sponsor
- Valeant Pharmaceuticals
- Start
- Jul 2009
- Primary completion
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of tretinoin in acne vulgaris, sponsored by Valeant Pharmaceuticals. Primary endpoint: Facial Irritation and Cutaneous Effects at 3 weeks. Started Jul 2009; status: completed.
02
Drugs
tretinoin
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT00952523.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00952523.